Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Molecular mechanisms for tumour resistance to chemotherapy
ST Pan, ZL Li, ZX He, JX Qiu… - Clinical and Experimental …, 2016 - Wiley Online Library
Chemotherapy is one of the prevailing methods used to treat malignant tumours, but the
outcome and prognosis of tumour patients are not optimistic. Cancer cells gradually …
outcome and prognosis of tumour patients are not optimistic. Cancer cells gradually …
Tetrazole hybrids with potential anticancer activity
J Zhang, S Wang, Y Ba, Z Xu - European journal of medicinal chemistry, 2019 - Elsevier
Cancer is one of the main causes of death throughout the world. The anticancer agents are
indispensable for the treatment of various cancers, but most of them currently on the market …
indispensable for the treatment of various cancers, but most of them currently on the market …
Endogenous mRNA triggered DNA‐Au nanomachine for in situ imaging and targeted multimodal synergistic cancer therapy
S Yu, Y Zhou, Y Sun, S Wu, T Xu… - Angewandte Chemie …, 2021 - Wiley Online Library
The development of versatile nanotheranostic platforms that integrate both diagnostic and
therapeutic functions have always been an intractable challenge in precise cancer …
therapeutic functions have always been an intractable challenge in precise cancer …
Survivin–the inconvenient IAP
DC Altieri - Seminars in cell & developmental biology, 2015 - Elsevier
Although technically a member of the Inhibitor of Apoptosis (IAP) gene family, survivin has
consistently defied assumptions, refuted predictions and challenged paradigms. Despite its …
consistently defied assumptions, refuted predictions and challenged paradigms. Despite its …
Survivin in survival of hepatocellular carcinoma
C Su - Cancer Letters, 2016 - Elsevier
Survivin is an anti-apoptotic protein belonging to the inhibitor of apoptosis protein (IAP)
family. It is involved in the regulation of important physiological and pathological processes …
family. It is involved in the regulation of important physiological and pathological processes …
Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis
X Chen, Y Zhang, C Tang, C Tian, Q Sun, Z Su… - International Journal of …, 2017 - Elsevier
The overexpression of survivin in breast cancer cells is an important factor of paclitaxel
(PTX) resistance in breast cancer. To overcome PTX resistance and improve the antitumor …
(PTX) resistance in breast cancer. To overcome PTX resistance and improve the antitumor …
PFKFB3 Regulates Chemoresistance, Metastasis and Stemness via IAP Proteins and the NF-κB Signaling Pathway in Ovarian Cancer
Y Jiang, MKY Siu, J Wang, THY Leung… - Frontiers in …, 2022 - frontiersin.org
Glycolysis has been reported to be critical for cancer stem cells (CSCs), which are
associated with tumor chemoresistance, metastasis and recurrence. Thus, selectively …
associated with tumor chemoresistance, metastasis and recurrence. Thus, selectively …
MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
Combined chemotherapeutic treatment is the method of choice for advanced and metastatic
gastric tumors. However, resistance to chemotherapeutic agents is one of the main …
gastric tumors. However, resistance to chemotherapeutic agents is one of the main …
miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer
Y Hu, K Xu, E Yagüe - Breast cancer research and treatment, 2015 - Springer
Multidrug resistance (MDR) remains one of the most significant obstacles in breast cancer
treatment, and this process often involves dysregulation of a great number of microRNAs …
treatment, and this process often involves dysregulation of a great number of microRNAs …
Vaccinia virus, a promising new therapeutic agent for pancreatic cancer
The poor prognosis of pancreatic cancer patients signifies a need for radically new
therapeutic strategies. Tumor-targeted oncolytic viruses have emerged as attractive …
therapeutic strategies. Tumor-targeted oncolytic viruses have emerged as attractive …